Concourse Financial Group Securities, Inc. Rocket Pharmaceuticals, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding RCKT
# of Institutions
243Shares Held
108MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$191 Million3.63% of portfolio
-
Wellington Management Group LLP Boston, MA14MShares$151 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$71 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$66.9 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$56.1 Million1.26% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $817M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...